Hussman Strategic Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.88M Sell
210,000
-105,000
-33% -$941K 0.43% 92
2025
Q1
$2.36M Buy
+315,000
New +$2.36M 0.57% 58